Monday, October 13, 2025
Home Authors Posts by Ogkologos

Ogkologos

4036 POSTS 0 COMMENTS

A Chemotherapy-Free Regimen of Tucatinib and Trastuzumab Shows Antitumour Activity with...

Ogkologos -
0

Understanding Genomic Correlates of Response and Acquired Resistance to FGFR Inhibitors

Ogkologos -
0

Efficacy and Safety of Datopotamab Deruxtecan in Patients with Pretreated Advanced/Metastatic...

Ogkologos -
0

FDA Grants Accelerated Approval to Encorafenib with Cetuximab and mFOLFOX6 for...

Ogkologos -
0

EMA Recommends Extension of Indications for Dostarlimab

Ogkologos -
0

Trastuzumab Emtansine Improves OS with Sustained Improvement in iDFS Among Patients...

Ogkologos -
0

Manageable Safety and Promising Activity of Neoadjuvant Pembrolizumab plus Vibostolimab, Pembrolizumab...

Ogkologos -
0

Dual Antigen Targeting with Talquetamab plus Teclistamab in Patients with Relapsed...

Ogkologos -
0

FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer

Ogkologos -
0

EMA Recommends Granting a Conditional Marketing Authorisation for Belzutifan

Ogkologos -
0
1...232425...404Page 24 of 404

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com